Cargando…

Mitochondrial Damage of Lymphocytes in Patients with Acute Relapse of Schizophrenia: A Correlational Study with Efficacy and Clinical Symptoms

OBJECTIVE: Accumulating evidence has demonstrated that schizophrenia is associated with mitochondrial and immune abnormalities. In this pilot case–control study, we investigated the level of mitochondrial impairment in lymphocytes in patients with acute relapse of schizophrenia and explored the corr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Aqian, Li, Faping, Guo, Lei, Zhao, Xiaoxi, Xiang, Xiaojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621005/ https://www.ncbi.nlm.nih.gov/pubmed/36325435 http://dx.doi.org/10.2147/NDT.S380353

Ejemplares similares

Reduction of Orexin-A Is Associated With Anxiety and the Level of Depression of Male Methamphetamine Users During the Initial Withdrawal Period
por: Guo, Lei, et al.
Publicado: (2022)

The transition of alcohol control in China 1990-2019: Impacts and recommendations
por: Hu, Aqian, et al.
Publicado: (2022)

The Neutrophil-Lymphocyte Ratio Is Positively Correlated with Aggression in Schizophrenia
por: Tong, Zhu, et al.
Publicado: (2022)

Economic burden in Medicaid beneficiaries with recently relapsed schizophrenia or with uncontrolled symptoms of schizophrenia not adherent to antipsychotics
por: Pilon, Dominic, et al.
Publicado: (2021)

The efficacy of homestyle rehabilitation on negative symptoms in chronic schizophrenia: A randomized controlled trial
por: Chai, Jiabao, et al.
Publicado: (2023)

Evaluation of Changes in Peripheric Biomarkers Related to Blood Brain Barrier Damage in Patients with Schizophrenia and Their Correlation with Symptoms
por: Yazla, Ece, et al.
Publicado: (2022)

The nature of relapse in schizophrenia
por: Emsley, Robin, et al.
Publicado: (2013)

The cost of relapse and the predictors of relapse in the treatment of schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2010)

Neurobiology of Schizophrenia: Search for the Elusive Correlation with Symptoms
por: Mathalon, Daniel H., et al.
Publicado: (2012)

Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma
por: Song, Yuqin, et al.
Publicado: (2023)

The Associations of Neutrophil–Lymphocyte, Platelet–Lymphocyte, Monocyte–Lymphocyte Ratios and Immune-Inflammation Index with Negative Symptoms in Patients with Schizophrenia
por: Šagud, Marina, et al.
Publicado: (2023)

Abnormal amygdala subregional-sensorimotor connectivity correlates with positive symptom in schizophrenia
por: Zhang, Meng, et al.
Publicado: (2020)

PHYSICAL HARBINGERS OF RELAPSE IN SCHIZOPHRENIA
por: Srinivasan, T.N., et al.
Publicado: (1994)

Polypharmacy and relapse of schizophrenia: are they related?
por: Softic, R., et al.
Publicado: (2022)

Correlation of neurocognitive deficits with positive and negative symptoms in schizophrenia
por: Priyamvada, Richa, et al.
Publicado: (2021)

Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
por: Kutsch, Nadine, et al.
Publicado: (2022)

Correlations between cortical gyrification and schizophrenia symptoms with and without comorbid hostility symptoms
por: Ferracuti, Stefano, et al.
Publicado: (2023)

Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia
por: Davidson, Michael, et al.
Publicado: (2022)

Quality of life is predictive of relapse in schizophrenia
por: Boyer, Laurent, et al.
Publicado: (2013)

C-Reactive Protein Correlates with Negative Symptoms in Patients with Schizophrenia
por: Boozalis, Ted, et al.
Publicado: (2018)

Cognitive-perceptual deficits and symptom correlates in first-episode schizophrenia
por: Olivier, Riaan M., et al.
Publicado: (2017)

Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia
por: Weng, Jiajun, et al.
Publicado: (2019)

Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
por: Kutsch, Nadine, et al.
Publicado: (2022)

Anomaly detection to predict relapse risk in schizophrenia
por: Henson, Philip, et al.
Publicado: (2021)

Visuospatial task-related prefrontal activity is correlated with negative symptoms in schizophrenia
por: Curtin, Adrian, et al.
Publicado: (2019)

Clinical Correlates of Insulin Resistance in Chronic Schizophrenia: Relationship to Negative Symptoms
por: Soontornniyomkij, Virawudh, et al.
Publicado: (2019)

Correlation analysis between insomnia symptoms and language function in patients with schizophrenia
por: Linlin, Wu, et al.
Publicado: (2023)

Mitochondrial, lysosomal and DNA damages induced by acrylamide attenuate by ellagic acid in human lymphocyte
por: Salimi, Ahmad, et al.
Publicado: (2021)

Extramedullary Involvement of the Ascending Colon in Relapsing Acute Lymphocytic Leukemia: A Case Report
por: Ifthikar, Zainab, et al.
Publicado: (2022)

Diffuse ST-segment elevation beyond acute coronary syndrome
por: Zhu, Hai, et al.
Publicado: (2023)

Differential diagnosis of acute intracranial hemorrhage and calcification by cranial dual-energy computed tomography
por: Song, Fang, et al.
Publicado: (2023)

Management of relapsed/refractory Chronic Lymphocytic Leukemia
por: Woyach, Jennifer A.
Publicado: (2022)

Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
por: Odetola, Oluwatobi, et al.
Publicado: (2023)

Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open‐label phase 3 study
por: Huang, Xiaojun, et al.
Publicado: (2018)

Negative symptoms of schizophrenia in patients with acute and transient psychotic disorders
por: Aleshkina, G., et al.
Publicado: (2021)

Elevated osteopontin and IFNy serum levels and increased neutrophil-to-lymphocyte ratio are associated with the severity of symptoms in schizophrenia
por: Kovács, M., et al.
Publicado: (2022)

STUDY OF RELAPSES IN SCHIZOPHRENIA USING THE LIFE TABLE METHOD
por: Thara, R., et al.
Publicado: (1987)

Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
por: García-Ruiz, Antonio J, et al.
Publicado: (2012)

Schizophrenia relapse, patient considerations, and potential role of lurasidone
por: Citrome, Leslie
Publicado: (2016)

Productivity and deadweight losses due to relapses of schizophrenia in Japan
por: Nakamura, Yusuke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kf0br9eidnik0ko6d1nseatsv0